ASPIRA PATHLAB & DIAGNOSTICS
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Operational & Financial Ratios | ||
| Earnings Per Share (Rs) | 1.97 | -2.60 |
| CEPS(Rs) | 3.42 | -1.10 |
| DPS(Rs) | - | - |
| Book NAV/Share(Rs) | 11.82 | 9.85 |
| Tax Rate(%) | - | - |
| Margin Ratios | ||
| Core EBITDA Margin(%) | 16.02 | -8.99 |
| EBIT Margin(%) | 10.77 | -17.45 |
| Pre Tax Margin(%) | 9.19 | -20.24 |
| PAT Margin (%) | 9.19 | -20.24 |
| Cash Profit Margin (%) | 15.98 | -8.58 |
| Performance Ratios | ||
| ROA(%) | 12.57 | -18.17 |
| ROE(%) | 18.13 | -26.34 |
| ROCE(%) | 19.27 | -20.54 |
| Asset Turnover(x) | 1.37 | 0.90 |
| Sales/Fixed Asset(x) | 1.24 | 0.77 |
| Working Capital/Sales(x) | 7.35 | 5.78 |
| Efficiency Ratios | ||
| Fixed Capital/Sales(x) | 0.81 | 1.30 |
| Receivable days | 38.11 | 61.98 |
| Inventory Days | 7.95 | 12.36 |
| Payable days | 72.32 | 101.10 |
| Valuation Parameters | ||
| PER(x) | 43.37 | - |
| PCE(x) | 24.95 | -28.15 |
| Price/Book(x) | 7.21 | 3.15 |
| Yield(%) | - | - |
| EV/Net Sales(x) | 3.95 | 2.39 |
| EV/Core EBITDA(x) | 22.18 | -41.27 |
| EV/EBIT(x) | 36.62 | -13.71 |
| EV/CE(x) | 6.49 | 2.82 |
| M Cap / Sales | 3.99 | 2.42 |
| Growth Ratio | ||
| Net Sales Growth(%) | 66.60 | - |
| Core EBITDA Growth(%) | 611.07 | - |
| EBIT Growth(%) | 202.84 | - |
| PAT Growth(%) | 175.69 | - |
| EPS Growth(%) | 175.69 | - |
| Financial Stability Ratios | ||
| Total Debt/Equity(x) | 0.10 | 0.11 |
| Current Ratio(x) | 2.26 | 2.10 |
| Quick Ratio(x) | 2.05 | 1.89 |
| Interest Cover(x) | 6.82 | -6.27 |
| Total Debt/Mcap(x) | 0.01 | 0.03 |
Compare Financial Ratios of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹114.7 Cr | 14.5% | -16.3% | 104.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹128,055.0 Cr | -0.9% | 2.9% | 20.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹107,532.0 Cr | 1.3% | -0.7% | -11.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,392.6 Cr | -2.8% | -1.3% | 18.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹70,919.3 Cr | -1.4% | 4.5% | 31.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹42,357.9 Cr | 2.8% | 4.9% | 0.6% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 14.5% |
-16.3% |
104.9% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses
